Description: Whistleblowing in Biomedical Research Policies and Procedures for Responding to Reports of Misconduct: Proceedings of a Workshop, September 21-22, 1981 Good - Text Unmarked - Binding and Cover Clean and Tight - Bumped Corners, Redacted Address Label on Back Cover` - Ready to Ship By -- Judith P. Swazey, Stephen R. Scher, AAAS Committee on Scientific Freedom and Responsibility, United States President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, Medicine in the Public Interest Published by -- President's Commission for the study of Ethical Problems in Medicine and Biomedical and Behavioral Research - US Government Printing Office, [1982], Washington, D.C., vi 208 Pages, Trade Paperback, 9" X 5.8" X .75", 13 oz. [PREFACE]The purpose of this two-day workshop was to examine the response of research institutions and federal agencies to reports of fraud or misconduct in federally supported biomedical research and to develop suggestions for improving such responses in the future. Incomplete or inaccurate research data, as well as violations of applicable regulations, may pose serious risks to research subjects. In addition, fraud in research may place future patients at risk if decisions to adopt or abandon a particular therapy are based upon incomplete or inaccurate data. More fundamentally, of course, fraud in research deeply affects the structure and conduct of science. (...) Individuals who report or "blow the whistle" on the wrongdoing by their colleagues or superiors may face retaliatory actions by their employers or superiors in the academic hierarchy; they may also encounter difficulties in having their charges taken seriously. Individuals accused of misconduct may believe the allegations to be spurious and may deeply resent disruption of their research during the conduct of an investigation. The federal agencies that disburse public monies to support the research have an obligation to protect the public's interests. These agencies also have an obligation to protect persons who report serious abuses, on the one hand, and not to overreact to unsubstantiated charges, on the other. (...)We believe that an informed discussion will assist both the federal government and the research community in developing policies and procedures for responding to the problem. This volume of workshop papers, commentaries, and summaries of discussion sessions has been prepared to encourage such a discussion. #HumanExperimentation #BooksBooksBooks #Antiquarian #BiomedicalResearch #readersofinstagram #Vintage #booksforsale #Congress #Books #Whistleblowing #bookcollecting #CoverArt #bibliophile #Bookstagram #MedicalEthics #CuttleboneBooks #Bioethics #instaread #GovernmentPrintingOffice #collectiblebooks #Bookworm #InformedConsent #booksale #instabooks
Price: 17.5 USD
Location: East Orange, New Jersey
End Time: 2025-01-07T16:01:28.000Z
Shipping Cost: 4.63 USD
Product Images
Item Specifics
Restocking Fee: No
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 30 Days
Refund will be given as: Money Back
Features: Government Publication, Government Document
Format: Trade Paperback
Topic: Books
Vintage: Yes
Country/Region of Manufacture: United States
Ex Libris: No
Language: English
Publication Year: 1982
Book Title: Whistleblowing in Biomedical Research Policies & Procedures(...)
Intended Audience: Ages 9-12, Young Adults, Adults
Author: AAAS Committee on Scientific Freedom and Responsibility, Judith P. Swazey, Medicine in the Public Interest, Stephen R. Scher
Original Language: English
Narrative Type: Nonfiction
Publisher: US Government Printing Office
Inscribed: No
Signed: No
Genre: Bioethics, Government Printing Office, Government Publication, Health, Treatments & Medicine, Medical Ethics
Personalized: No
Type: Proceedings